Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23770079.
- Also identified by DOI 10.1016/j.stem.2013.05.004 and PMC identifier 3703476.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Early full-term pregnancy is one of the most effective natural protections against breast cancer. To investigate this effect, we have characterized the global gene expression and epigenetic profiles of multiple cell types from normal breast tissue of nulliparous and parous women and carriers of BRCA1 or BRCA2 mutations. We found significant differences in CD44(+) progenitor cells, where the levels of many stem cell-related genes and pathways, including the cell-cycle regulator p27, are lower in parous women without BRCA1/BRCA2 mutations. We also noted a significant reduction in the frequency of CD44(+)p27(+) cells in parous women and showed, using explant cultures, that parity-related signaling pathways play a role in regulating the number of p27(+) cells and their proliferation. Our results suggest that pathways controlling p27(+) mammary epithelial cells and the numbers of these cells relate to breast cancer risk and can be explored for cancer risk assessment and prevention.
Medical subject headings
- Breast Neoplasms
- Cell Lineage
- Cyclin-Dependent Kinase Inhibitor p27
- Gene Expression Profiling
- Mammary Glands, Human
- Parity
- Stem Cells